IN2012DN03074A - - Google Patents

Download PDF

Info

Publication number
IN2012DN03074A
IN2012DN03074A IN3074DEN2012A IN2012DN03074A IN 2012DN03074 A IN2012DN03074 A IN 2012DN03074A IN 3074DEN2012 A IN3074DEN2012 A IN 3074DEN2012A IN 2012DN03074 A IN2012DN03074 A IN 2012DN03074A
Authority
IN
India
Prior art keywords
analogs
disease
treatment
well
pharmacokinetic properties
Prior art date
Application number
Other languages
English (en)
Inventor
Kazimierz A Wisniewski
Claudio Daniel Schteingart
Sudarkodi Alagarsamy
Guangcheng Jian
Pierre Riviere
Javier Sueiras-Diaz
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP09173900A external-priority patent/EP2314616A1/en
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of IN2012DN03074A publication Critical patent/IN2012DN03074A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IN3074DEN2012 2009-10-23 2010-10-21 IN2012DN03074A (https=)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25449009P 2009-10-23 2009-10-23
EP09173900A EP2314616A1 (en) 2009-10-23 2009-10-23 Peptidic GLP-2 agonists
PCT/US2010/053570 WO2011050174A1 (en) 2009-10-23 2010-10-21 Peptidic glp-2 agonists

Publications (1)

Publication Number Publication Date
IN2012DN03074A true IN2012DN03074A (https=) 2015-07-31

Family

ID=53052624

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3074DEN2012 IN2012DN03074A (https=) 2009-10-23 2010-10-21

Country Status (4)

Country Link
HR (1) HRP20150211T1 (https=)
IN (1) IN2012DN03074A (https=)
SA (1) SA110310791B1 (https=)
SM (1) SMT201500065B (https=)

Also Published As

Publication number Publication date
SMT201500065B (it) 2015-05-05
SA110310791B1 (ar) 2014-06-04
HRP20150211T1 (hr) 2015-06-05
HK1173659A1 (en) 2013-05-24

Similar Documents

Publication Publication Date Title
JO3026B1 (ar) مستضادات ببتيد شبيه الجلوكاجون - 2
IN2012DN02737A (https=)
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
MX2012013375A (es) Peptido c pegilado.
EA201170465A1 (ru) Способы лечения прогрессирующего множественного склероза
TN2012000161A1 (en) Spiro-oxindole mdm2 antagonists
UA102432C2 (ru) Цитотоксичные конъюгаты с соединением, которое связывает рецептор нейропептиду y
IT1395519B1 (it) Pezzo composito, nonche' impiego del pezzo composito
IN2014DN06104A (https=)
MX356728B (es) Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2.
AP2014007399A0 (en) Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament
CL2011001427A1 (es) Compuestos derivados de 4-azetidinil-1-heteroaril-ciclohexanol; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, aterosclerosis, artritis reumatoide, entre otras.
IN2015DN00515A (https=)
UA96574C2 (ru) Использование ивабрадина для получения лекарств, предназначенных для лечения эндотелиальной дисфункции
IN2012DN03074A (https=)
MX2012004727A (es) Agonistas peptidicos del glp-2.
UA44395U (ru) Применение тиоцетама в качестве диуретического средства с мягким мочегонным действием в комплексном лечении
AU329952S (en) Book
PA8849101A1 (es) Procedimiento de preparación del hemifumarato de eplivanserina
UA41660U (en) Use of jacton and mexidol as actoprotector
UA92646C2 (ru) применение производных 2-оксоиндолин-3-глиоксиловой кислоты в качестве средств с актопротекторным действием
HUP0900258A2 (en) The treatment of brain tumours by pyrithiamine
UA41922U (ru) Применение альтана как вещества с противолучевыми свойствами
TH93145B (th) เครื่องคิดเลขไฟฟ้า
TH95698B (th) เชิงเทียน